Price List - Gywn Lo - Contraceptive Agents - Misc.xlsx

XLSX spreadsheet 44 KB Posted

Attached to
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation number
HT9402-26-Q-9403
Issued by

About this file

This is a pricing template for the Department of War (DoW) Pharmacy and Therapeutics (P&T) Committee's November 2026 review of newly approved contraceptive agents in the miscellaneous subclass. The price list is designated for a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) procurement under solicitation HT9402-26-Q-9403 issued by the Defense Health Agency. The template covers ten newly approved drug entries, each requiring pricing submissions for both Uniform Formulary (UF) and Non-Formulary (NF) scenarios with no step therapy requirements at military treatment facilities and mail order venues. Manufacturers must submit quotes with price per NDC package size and price per unit, along with a completed Quote Review Checklist and fully executed signature pages by the deadline of September 24, 2026.

The pricing template includes multiple pricing appendices addressing different reimbursement mechanisms: BPA pricing (fixed price per unit of measure across all package sizes), ADP non-FAMP discount pricing (calculating total refunds based on non-FAMP price plus additional manufacturer discounts), and ADP WAC discount pricing (for products without Federal Ceiling Pricing using Wholesale Acquisition Cost from First Databank). For TRICARE retail refunds under the ADP sections, manufacturers must provide pricing for Tier 2 and Tier 3 formulary categories. A prior authorization may apply per class notes, and the P&T Committee meeting is scheduled for November 4-5, 2026, with a pre-quotation teleconference on September 9, 2026.

View the file

Other files

File Type Posted
Formulary Placement of FDA NADs.pdf PDF
RFQ HT9402-26-Q-9403 NAD.pdf PDF
Price List - Furoscix ReadyFlow - Diuretics - NA.xlsx XLSX spreadsheet
Price List - Jideytro - Lung Cancer - NA.xlsx XLSX spreadsheet
Price List - Zenbexus - Multiple Myeloma - NA.xlsx XLSX spreadsheet
Price List - Omlyclo - Atopy - NA.xlsx XLSX spreadsheet
Price Appendix FAQ NAD.pdf PDF
Price List - RizaFilm - Migraine Agents - NA.xlsx XLSX spreadsheet

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

BPA

UF BPA NDC Price List for the November 2026 DoW P&T Meeting
DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
Formulary Notes
Class Note(s): Prior Authorization (PA) may apply.

Step Therapy Addendum: N/A

Notes to Manufacturers: Do not forget to submit the Quote Review Checklist and fully executed signature pages, along with quote information.

The price per unit of measure for a given dosage form and strength (each, gram, mL, etc.) of the pharmaceutical agent will be the same for all available package sizes (e.g., 30s, 100s, 1000s) within a given dispensing venue.

Blanket Purchase Agreement Appendix – Newly Approved Drug

#1DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#2DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#3DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#4DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#5DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#6DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#7DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

Blanket Purchase Agreement Appendix – Newly Approved Drug

#8DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#9DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote
Blanket Purchase Agreement Appendix – Newly Approved Drug
#10DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeMilitary Treatment Facility & Mail Order

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Price per NDC Package Size Price per Unit

Scenario 1162OCMUN0UFNS1MUniform Formulary
No Step Therapy1 or moreNO QUOTE
162OCMUN0NFNS1MNon-Formulary
No Step Therapy1 or moreNO QUOTE
If cell highlights red, please confirm intent not to submit a quote

&"-,Italic"Use or disclosure of data contained on this sheet is subject to the restriction on the title page of this quote.

ADP (non-FAMP Discount)

UF ADP Appendix for the November 2026 DoW P&T Meeting
DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
Formulary Notes
Class Note(s): Prior Authorization (PA) may apply.

Notes to Manufacturers: Do not forget to submit the Quote Review Checklist and fully executed signature pages, along with quote information.

* Total Calculated Refund Per FCP is calculated as: ((non-FAMP-FCP)+(non-FAMP*Y%)) = Total Calculated Refund **Based on the most recent annual non-FAMP (reported to the Department of Veterans Affairs) from which the current annual Federal Ceiling Price (FCP) calculated ceiling is derived. The current annual FCP and the annual non-FAMP from which it is derived will be applicable to all prescriptions filled during a calendar year. The quoted additional refund percentage will remain static during the life of the agreement but the most recent annual non-FAMP, and thus the calculated refund, may change each calendar year.

Additional Discount Program Appendix – Newly Approved Drug

#1DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#2DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#3DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#4DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote
Additional Discount Program Appendix – Newly Approved Drug
#5DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#6DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#7DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#8DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#9DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote
Additional Discount Program Appendix – Newly Approved Drug
#10DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category Description One of (x) Number of Brand Agents Non-FAMP Price of Drug Per FCP Package** Additional Offered Refund Per FCP Package** Current Annual Federal Ceiling Price Per FCP Package** Standard Refund Per FCP Total Calculated Retail Refund Per FCP Package*

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

&"-,Italic"Use or disclosure of data contained on this sheet is subject to the restriction on the title page of this quote.

ADP (WAC Discount)

UF ADP Appendix for the November 2026 DoW P&T Meeting
DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
Formulary Notes
Class Note(s): Prior Authorization (PA) may apply.

Notes to Manufacturers: Do not forget to submit the Quote Review Checklist and fully executed signature pages, along with quote information.

The Wholesale Acquisition Cost (WAC) is obtained from First Databank via daily price updates; it is maintained at the dispensing unit level to five (5) decimal places. If the WAC changes during a calendar quarter, an average WAC will be calculated on a daily weighted basis (per unit only).

WAC is ONLY used for products that do not have a FCP, such as diabetic supplies (i.e., test strips), and can also be applied to covered drugs.

*The quoted WAC Discount percentage will remain static during the life of the agreement.

Additional Discount Program Appendix – Newly Approved Drug

#1DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#2DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#3DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#4DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#5DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#6DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#7DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#8DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#9DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

Additional Discount Program Appendix – Newly Approved Drug

#10DoW Uniform Formulary Class:CONTRACEPTIVE AGENTSP&T Committee Meeting:November 4-5, 2026
DoW Uniform Formulary Subclass:MISCELLANEOUSQuotes due:September 24, 2026
NDC NumberDrug NameStrengthDosage FormPackage SizeTRICARE RETAIL REFUND

Formulary Scenarios Condition Set # Formulary Category One of (x) Number of Brand Agents WAC Price of Drug WAC Discount* Total Calculated Retail Refund per Package

Scenario 1162OCMUN0T2NS1MTier 2
No Step Therapy1 or more
162OCMUN0T3NS1MTier 3
No Step Therapy1 or more
If cell highlights red, please confirm intent not to submit a quote

&"-,Italic"Use or disclosure of data contained on this sheet is subject to the restriction on the title page of this quote.

File details come from the government source that posted it. Updated .